课题基金 / 基金详情

CHARACTERIZATION OF GP35--A SIGNAL TRANSDUCER ON NK CELL

CHARACTERIZATION OF GP35--A SIGNAL TRANSDUCER ON NK CELL
NK细胞信号转导器GP35的表征
批准号:
3197486
负责人:
John B Imboden
金额:
$9.15万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-08-06 至 1995-05-31

项目摘要

项目成果

John B Imboden的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(改编自申请人摘要)拟定研究 gp 35是一种33-40 kD的糖蛋白, 与配体结合结构相互作用的信号转导分子 以调节NK细胞和T细胞的细胞反应。 的 具体的目的是:1)确定gp 35单抗是否是促有丝分裂的, 新鲜分离的NK细胞,影响NK细胞的细胞溶解活性,和 激活NK细胞产生细胞因子; 2)确定是否有 与NK上gp 35物理相关的细胞表面分子 细胞和T细胞; 3)通过产生gp 35缺失突变体, RNK-16,gp 35是否是靶细胞诱导的PPI周转所必需的 在RNK-16内,用于细胞毒性和用于CD 2介导的信号传导;和4) 克隆编码gp 35的基因。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) The proposed studies will address the hypothesis that gp35 a 33-40 kD glycoprotein is a signal-transducing molecule that interacts with ligand-binding structures in order to regulate the cellular responses of NK cells and T cells. The specific aims are: 1) to determine whether gp35 MAb are mitogenic for freshly isolated NK cells, affect the cytolytic activity of NK cells, and activate NK cells to produce cytokines; 2) to determine whether there are cell-surface molecules which are physically associated with gp35 on NK cells and T cells; 3) to determine, by generating gp35-loss mutants of RNK-16, whether gp35 is required for target cell-induced PPI turnover within RNK-16, for cytotoxicity, and for CD2-mediated signaling; and 4) to clone the gene that encodes gp35.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunodominant Epitopes in Kawasaki Disease
Immunodominant Epitopes in Kawasaki Disease
MUTATIONAL ANALYSIS OF CTLA-4 FUNCTION IN VIVO
MUTATIONAL ANALYSIS OF CTLA-4 FUNCTION IN VIVO
海外基金